ChromaDex partners with 1health to launch test kit leveraging dried blood spot assay tech, offering NAD+ level tracking for personalized care.
Los Angeles-based ChromaDex has unveiled its Niagen+ NAD+ Test Kit. This advanced diagnostic tool, available exclusively through healthcare practitioners, aims to enhance patient care by providing reliable, accurate measurement of blood NAD+ levels– a critical factor in cellular health and energy regeneration.
Longevity.Technology: NAD+ is a coenzyme essential for various biological processes, playing a pivotal role in cellular energy production and overall cellular health. As people age, NAD+ levels naturally decline, contributing to diminished cellular function and vitality. The health and wellness industry has seen a surge in interest in NAD+ due to its potential antiaging benefits, resulting in a proliferation of NAD+ products including supplements, IV treatments and beauty products. The market for testing NAD+ levels and supplementing with NAD+ precursors such as nicotinamide riboside (NR) has grown considerably, reflecting the demand for solutions to counteract age-related declines in NAD+.
ChromaDex’s new test kit, developed in collaboration with Revvity, employs advanced dried blood spot (DBS) assay technology to ensure the stability of NAD+ samples during transport. This innovative approach allows for precise and accurate results, addressing the limitations of some other test kits that rely on less reliable DBS cards which necessitate a fixer solution to stabilize NAD+.
ChromaDex CEO Rob Fried emphasized the company’s commitment to high scientific standards, stating: “The Niagen+ NAD+ Test Kit exemplifies our commitment to innovative tools that enable precise measurement and personalized patient care.”
The kit is designed to integrate smoothly into healthcare practitioners’ protocols, allowing them to monitor NAD+ levels over time and tailor treatments to individual patient needs. By using the kit, practitioners can establish a baseline NAD+ level before initiating supplementation – perhaps with ChromaDex’s Tru Niagen products or its newly introduced Niagen+ IV therapy – and then track changes to optimize therapeutic outcomes.
Key features of the Niagen+ NAD+ Test Kit include:
- Innovative test card technology: A unique DBS card maintains NAD+ stability throughout transport, ensuring accurate measurements.
- Baseline and progress tracking: Enables practitioners to establish baseline NAD+ levels and monitor changes post-therapy.
- Validated results: Analyses are conducted in a CLIA and CAP accredited laboratory using high-resolution liquid chromatography/tandem mass spectrometry (LC-MS/MS).
- Precision analysis: Ensures precise measurement of NAD+ levels, providing critical data for personalized treatment protocols.
The test has been designed to be straightforward; healthcare practitioners provide patients with an at-home kit, which the patients register on the 1health platform. Following the instructions, patients collect a blood sample using the DBS card and send it to the laboratory in a prepaid envelope. Results are typically available within two weeks and can be accessed by both patients and their doctors through the 1health platform.
Mehdi Maghsoodnia, CEO of 1health, highlighted the importance of their platform in the successful deployment of the Niagen+ NAD+ Test Kit. “Our robust software seamlessly integrates with both the warehouse and the lab, ensuring efficient fulfillment of kits and accurate delivery of results,” he explained. “This collaboration provides invaluable insights for practitioners aiming to optimize their patients’ NAD+ levels, enabling personalized and effective NAD+ boosting protocols, such as Tru Niagen oral supplementation and soon Niagen IV and injection, to maximize therapeutic outcomes.”
Precise measurements and personalized treatment protocols are the future of longevity supplementation. As NAD+ continues to be a focal point in the quest for improved healthspan and longevity, the launch of the Niagen+ NAD+ Test Kit offers healthcare practitioners a reliable tool to enhance patient outcomes through a personalized and precisely measured approach.
Image courtesy of ChromaDex
